Rabeprazole-SZ capsules

To favorites
Rabeprazole-SZ capsules An agent that lowers the secretion of gastric glands - a proton pump inhibitor
Active substance:Rabeprazole
Pharmacological group:Gastrointestinal medications
Country of origin:Russia
In stock
In stock
In stock
We deliver goods to almost any country. Each parcel is assigned a track number
You can pay by Paypal or any card Visa or Mastercard
Discount system
Cumulative discounts and Bonus program for our clients
Original goods
We offer our customers only original products

Instructions for Rabeprazole-SZ capsules

English product name

Release form
intestinal soluble 20 mg: 5, 7, 10, 14, 15, 20, 21, 28, 30 or 60 pcs


Intestinal-soluble capsules 1 cap.
sodium rabeprazole 20 mg

ATC codes
A02BC04 Rabeprazole

Clinical-pharmacological groups / Group affiliation
H<SUP>+</SUP>-C<SUP>+</SUP>-ATP-ase inhibitor. Antiulcer preparation

Active substance
sodium rabeprazole

Pharmacotherapy group
Proton pump inhibitor

Pharmacological effect:

The inventive antiulcer agent is used for inhibiting H+-K+-ATP-ase (proton pump). The mechanism of action is connected with oppression of the enzyme H+-K+-ATP-ase in parietal cells of the stomach, which leads to blocking the final stage of formation of hydrochloric acid. This action is dose-dependent and leads to the suppression of both basal and stimulated hydrochloric acid secretion regardless of the nature of the stimulus.


Stomach and duodenal ulcer disease in the exacerbation phase; stomach and duodenal ulcer disease associated with Helicobacter pylori (in combination with antibiotics); gastroesophageal reflux.

Dosage, Course and Dosage:

Inwards. The dosage regimen is set individually, depending on the indications and treatment regimen.

Use in liver disorders
Patients with liver function disorders do not need dose correction, but in patients with severe liver function disorders, rabeprazole is recommended to be used with caution.

Use in children
Use in children and adolescents under the age of 18 is contraindicated.

  • Nosology (ICD codes)
  • B98.0
  • Helicobacter pylori as the cause of diseases classified in other categories
  • K21
  • Gastroesophageal reflux
  • K25
  • Stomach ulcer
  • K26
  • Duodenum ulcer
Active substance
Pharmacological group
Country of origin
Expiration Date (in months)
No reviews yet — your comment may be first.
All reviews 0
general rating